AR122280A1 - ANTIVIRAL HETEROCYCLIC COMPOUNDS - Google Patents
ANTIVIRAL HETEROCYCLIC COMPOUNDSInfo
- Publication number
- AR122280A1 AR122280A1 ARP200101989A ARP200101989A AR122280A1 AR 122280 A1 AR122280 A1 AR 122280A1 AR P200101989 A ARP200101989 A AR P200101989A AR P200101989 A ARP200101989 A AR P200101989A AR 122280 A1 AR122280 A1 AR 122280A1
- Authority
- AR
- Argentina
- Prior art keywords
- hrsv
- present
- compounds
- hmpv
- heterocyclic compounds
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 241000342334 Human metapneumovirus Species 0.000 abstract 4
- 241000711920 Human orthopneumovirus Species 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención revela compuestos de fórmula (1), o sales, ésteres o fármacos precursores del mismo de uso farmacéutico aceptable, los cuales inhiben al Virus Sincicial Respiratorio Humano (HRSV) o inhibidores del Metaneumovirus Humano (HMPV). La presente invención además se relaciona a composiciones farmacéuticas que comprenden los compuestos recién mencionados para administrarlos a un sujeto que padece de una infección por HRSV o HMPV. La invención también se relaciona a métodos de tratamiento de una infección por HRSV o HMPV en un sujeto mediante la administración de una composición farmacéutica que comprende los compuestos de la presente invención.The present invention discloses compounds of formula (1), or pharmaceutically acceptable salts, esters or precursor drugs thereof, which inhibit Human Respiratory Syncytial Virus (HRSV) or inhibitors of Human Metapneumovirus (HMPV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from an HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962910712P | 2019-10-04 | 2019-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR122280A1 true AR122280A1 (en) | 2022-08-31 |
Family
ID=83218706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP200101989A AR122280A1 (en) | 2019-10-04 | 2020-07-15 | ANTIVIRAL HETEROCYCLIC COMPOUNDS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR122280A1 (en) |
-
2020
- 2020-07-15 AR ARP200101989A patent/AR122280A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022003984A (en) | HETEROCYCLIC ANTIVIRAL COMPOUNDS. | |
| UY39032A (en) | HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS | |
| UY38614A (en) | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | |
| UY39642A (en) | ANTIVIRAL HETEROCYCLIC COMPOUNDS | |
| PH12018500147A1 (en) | Benzodiazepine derivatives as rsv inhibitors | |
| WO2017123884A8 (en) | Heterocyclic compounds as rsv inhibitors | |
| AR129003A1 (en) | HETEROCYCLIC ANTIVIRAL COMPOUNDS | |
| EA201992082A1 (en) | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | |
| SA519410865B1 (en) | Coumarin-like Cyclic Compound as MEK Inhibitor and Use Thereof | |
| AR108046A1 (en) | INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE | |
| MX2021010106A (en) | Inhibitors of integrated stress response pathway. | |
| MY207696A (en) | 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof | |
| SA519402103B1 (en) | 1, 6- Naphthyridine as CDK4/6 Inhibitor | |
| EA202191955A1 (en) | MODIFIED RELEASE TABLET FORMULATIONS CONTAINING PHOSPHODIESTERASE INHIBITORS | |
| CR20220196A (en) | COMPLEMENT FACTOR D INHIBITORS FOR ORAL ADMINISTRATION | |
| BR112021025618A2 (en) | Compound, method of preventing, treating or lessening the severity of a disease, pharmaceutical composition and use of a compound | |
| BR112021020027A2 (en) | Compounds, compositions and methods | |
| AR122280A1 (en) | ANTIVIRAL HETEROCYCLIC COMPOUNDS | |
| AR118379A1 (en) | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | |
| BR112022006298A2 (en) | HETEROCYCLIC ANTIVIRAL COMPOUNDS | |
| AR120158A2 (en) | SUBSTITUTED INDOL MONO OR DI DERIVATIVES AS INHIBITORS OF DENGUE VIRAL REPLICATION | |
| EA202192511A1 (en) | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | |
| AR129293A1 (en) | INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS | |
| DOP2024000229A (en) | INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS | |
| PH12022550895A1 (en) | Compositions for preventing or treating chronic obstructive pulmonary diseases (copd) |